Clinical study: myocardial infarction
Acute myocardial infarction in the elderly: differences by age

https://doi.org/10.1016/S0735-1097(01)01432-2Get rights and content
Under an Elsevier user license
open archive

Abstract

OBJECTIVES

We evaluated the clinical characteristics and outcomes of elderly patients hospitalized with acute myocardial infarction (AMI) to describe differences by age.

BACKGROUND

Elderly patients with AMI are perceived as a homogeneous population, though the extent by which clinical characteristics vary among elderly patients has not been well described.

METHODS

Data from 163,140 hospital admissions of Medicare beneficiaries age ≥65 years between 1994 and 1996 with AMI at U.S. hospitals were evaluated for differences in clinical characteristics and mortality across five age-based strata (in years): 65 to 69, 70 to 74, 75 to 79, 80 to 84 and ≥85.

RESULTS

Older age was associated with a greater proportion of patients with functional limitations, heart failure, prior coronary disease and renal insufficiency and a lower proportion of male and diabetic patients. Of note, the proportion of patients presenting with chest pain within 6 h of symptom onset, and with ST-segment elevation, was lower in each successive age group. Thirty-day mortality rates were higher in older age groups (65 to 69: 10.9%, 70 to 74: 14.1%, 75 to 79: 18.5%, 80 to 84: 23.2%, ≥85: 31.2%, p = 0.001 for trend). The effect of age persisted but was attenuated after adjustment for differences in patient characteristics; similar trends were observed for one-year mortality.

CONCLUSIONS

Our data indicate significant age-associated differences in clinical characteristics in elderly patients with AMI, which account for some of the age-associated differences in mortality. The practice of grouping older patients together as a single age group may obscure important age-associated differences.

Abbreviations

AMI
acute myocardial infarction
CABG
coronary artery bypass graft
CCP
Cooperative Cardiovascular Project
PTCA
percutaneous transluminal coronary angioplasty

Cited by (0)

Dr. Mehta is the recipient of an NIH supported K-30 award through the Center for Clinical Investigation and Therapeutics and the General Clinical Research Center, University of Michigan, Ann Arbor, Michigan.